Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 192Neoplasms 147Prostatic Neoplasms 101Lung Neoplasms 90Carcinoma, Non-Small-Cell Lung 62Colorectal Neoplasms 59Head and Neck Neoplasms 52Pancreatic Neoplasms 46Carcinoma, Hepatocellular 44Rectal Neoplasms 42Brain Neoplasms 41Multiple Myeloma 39Colonic Neoplasms 37Esophageal Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 30Leukemia, Myeloid, Acute 30Ovarian Neoplasms 29Lymphoma, Non-Hodgkin 29Leukemia 29Lymphoma 28Motor Activity 25Hodgkin Disease 24Uterine Cervical Neoplasms 23Carcinoma, Renal Cell 23Pain 22Lymphoma, Follicular 22Depression 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioma 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × Hypoglycemia × Clear all
NCT04452396 2023-12-12

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Barts & The London NHS Trust

Phase NA Terminated
7 enrolled
Endocrine

Hypoglycemia, Insulin Resistance, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡